The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about 8 days, but there is a wide range of variability from person to person. Understanding how long people can remain actively infected is important, because it provides new details about a disease and a virus that are still not well understood and informs public health decisions.
Researchers report in the journal Cell an unusual case of one woman with leukemia and a low antibody count who was infected with the coronavirus for at least 105 days, and infectious for at least 70, while remaining asymptomatic the entire time.
"At the time we started this study, we really didn't know much about the duration of virus shedding," says senior author. "As this virus continues to spread, more people with a range of immunosuppressing disorders will become infected, and it's important to understand how SARS-CoV-2 behaves in these populations."
The patient, a 71-year-old woman, was immunocompromised due to chronic lymphocytic leukemia and acquired hypogammaglobulinemia. She never showed any symptoms of COVID-19. She was found to be infected with the virus when she was screened after being admitted to the hospital for severe anemia and her doctors recognized that she had been a resident of a rehabilitation facility experiencing a large outbreak.
The authors found that infectious virus continued to be present for at least 70 days after the first positive test, and the woman didn't fully clear the virus until after day 105. "This was something that we expected might happen, but it had never been reported before," the author says.
The investigators believe the patient remained infectious for so long because her compromised immune system never allowed her to mount a response. Blood tests showed that her body was never able to make antibodies. At one point she was treated with convalescent plasma, but Munster doesn't think the treatment had an effect because of its low concentration of antibodies. Despite her inability to mount an antibody response, she never went on to develop COVID-19.
The team performed deep sequencing on all the virus samples obtained from the patient to see how the virus might have changed over the course of the patient's infection. Samples collected at various times displayed different dominant gene variants. However, the investigators don't think that these mutations played a role in how long the virus persisted, because they saw no evidence of natural selection. Selection would have been implicated if one of the variants had appeared to provide the virus with a survival benefit and had become the dominant variant, but none of them did. They also tested whether or not the mutations affected the ability or speed of the virus to replicate and found no differences.
The authors say that this is the longest case of anyone being actively infect-ed with SARS-CoV-2 while remaining asymptomatic. "We've seen similar cases with influenza and with Middle East respiratory syndrome, which is also caused by a coronavirus," the author notes. "We expect to see more reports like ours coming out in the future."
https://www.cell.com/cell/fulltext/S0092-8674(20)31456-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcase-study-prolonged&filter=22
A leukemia patient sheds infectious SARS-CoV-2 for at least 70 days
- 1,762 views
- Added
Edited
Latest News
Psychosocial experiences ar…
By newseditor
Posted 25 Jun
How a microbe and a prebiot…
By newseditor
Posted 24 Jun
Slowing inflammation may bo…
By newseditor
Posted 24 Jun
Cellular senescence in norm…
By newseditor
Posted 24 Jun
Neuronal communication capt…
By newseditor
Posted 24 Jun
Other Top Stories
Restoring glucose production by glucagon through calcium mediated i…
Read more
The glial role in feeling satiety after a meal
Read more
Brain aging could be detected early and reversed by low carb diet
Read more
Are bacteria involved in the development of type 2 diabetes?
Read more
Protein controls fat metabolism
Read more
Protocols
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Publications
Nicotinamide metabolism fac…
By newseditor
Posted 26 Jun
Tonic type 2 immunity is a…
By newseditor
Posted 26 Jun
An unexpected role for the…
By newseditor
Posted 25 Jun
Coordinated action of a gut…
By newseditor
Posted 25 Jun
Safety of non-replicative a…
By newseditor
Posted 25 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar